Business · 29/11/2010
FDA Releases Draft Guidance for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Treatment
The FDA is releasing a draft guidance to help clinical trial sponsors and investigators develop effective treatments for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
Original source language: Federal Register — Health and Human ServicesOpen original release →